Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion type Assertion NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_head.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion description "[Therefore, SHIP2 remains a significant therapeutic target for the treatment of both obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_provenance.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion evidence source_evidence_literature NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_provenance.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion SIO_000772 15964236 NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_provenance.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion wasDerivedFrom befree-2016 NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_provenance.
- NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_assertion wasGeneratedBy ECO_0000203 NP500087.RALOHYn1fRZPNbVQo4t_EGCixgjuCXdRkTW5HW8h5Em_o130_provenance.